BioSpace News Archive

Genetown

Tectonic Therapeutic Announces Start of First Clinical Program for GPCR-Targeted Biologic

Tectonic Therapeutic, Inc. today announced it completed dosing of the first human cohort in its Fc-relaxin fusion program targeting the RXFP1 receptor.

November 28, 2023
·
2 min read
Drug Development

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Initiate Phase 1/2a Study of ARO-DM1 for Type 1 Myotonic Dystrophy

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has filed an application for clearance to initiate a Phase 1/2a clinical trial of ARO-DM1, the company’s investigational RNA interference (RNAi) therapeutic being developed as a potential treatment for type 1 myotonic dystrophy (DM1), the most common adult-onset muscular dystrophy.

November 28, 2023
·
5 min read
Novocure Announces Portfolio Prioritization and Strategic Restructuring Plan Focused on Near-term Growth Drivers and an Accelerated Path to Profitability

Novocure (NASDAQ: NVCR) today announced a series of actions to strengthen and optimize business operations to support near-term growth drivers and long-term value creation.

November 28, 2023
·
5 min read
Pharm Country

Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference

Onconova Therapeutics, Inc. today announced that Steven Fruchtman, M.D., President & CEO, will present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference, being held December 3-5, 2023 at Florida Atlantic University.

November 28, 2023
·
2 min read
FDA

eFFECTOR Receives U.S. FDA Fast Track Designation for Zotatifin in Combination with Fulvestrant and Abemaciclib for Treatment of ER+/HER2- Advanced Metastatic Breast Cancer

eFFECTOR Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for zotatifin.

November 28, 2023
·
6 min read
Genetown

ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype

ReWalk Robotics, Ltd. announced the successful demonstration of a proof-of-concept next-generation exoskeleton.

November 28, 2023
·
4 min read
Pharm Country

Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced the U.S. commercial availability of VOQUEZNA® (vonoprazan).

November 28, 2023
·
17 min read
Genetown

Spyre Therapeutics to Present at Upcoming November 2023 Investor Conference

Spyre Therapeutics, Inc., a biotechnology company advancing a pipeline of antibody therapeutics with the potential to transform the treatment of inflammatory bowel disease, announced that Cameron Turtle, D.Phil., CEO of Spyre Therapeutics will participate in an upcoming investor conference.

November 28, 2023
·
1 min read
BioMidwest

Lilly Announces Plans to Open its First-ever Gateway Labs Site in San Diego

Eli Lilly and Company announced plans to open its first-ever Lilly Gateway Labs location in San Diego, Calif. in the first half of 2024.

November 28, 2023
·
3 min read
IceCure System Successfully Treated Kidney Cancer Tumor with 92% Disease-Free Survival Rate and 100% Secondary Local Control Rate

IceCure Medical Ltd. announced the latest release of a study in a series of independent studies of ProSense® published in peer-reviewed journals demonstrating safety and efficacy.

November 28, 2023
·
6 min read